immunAware ApS

Private limited companyCVR 39189135HørsholmActive

immunAware ApS is a private limited company, based in Hørsholm, active in research and experimental development on natural sciences and engineering, founded in 2017. The company made a loss in both 2024 and 2025, most recently DKK 339k. 4 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 4.6m+14% vs. 2024
Net profit−DKK 339k+55.3% vs. 2024
EquityDKK 4.9m−6.4% vs. 2024
Employees8latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 14% (2024 → 2025), to DKK 4.6m.
  • The loss got smaller: from DKK 757k to DKK 339k (2024 → 2025).
  • Equity fell 6% (2024 → 2025), to DKK 4.9m.

Employees

  • 1 fewer employees than a year earlier: 8 (07/2026) against 9 (07/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 1mDKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5mDKK 6m202020212022202320242025
EquityNet profit
Financial figures for immunAware ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit2,3953,4285,0955,4384,0584,627+14%
Operating profit (EBIT)–1,4801,9421,709−992−451+54.5%
Profit before tax1,4731,4641,8981,654−1,005−486+51.7%
Net profit1,2111,1831,5671,309−757−339+55.3%
Total assets3,2474,1735,4567,1205,7825,241−9.4%
Equity2,5913,6145,0216,1705,2524,914−6.4%
Liabilities582504318834530328−38.2%
Cash and cash equivalents1,8772,0262,4254,0452,4281,746−28.1%
Average number of employees135689+12.5%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for immunAware ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202505/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202416/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202311/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202212/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202116/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202016/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 4.6mNo. 121 of 421
Better than 71% of the companies in the industry
EquityDKK 4.9mNo. 178 of 431
Better than 59% of the companies in the industry
Number of employees8No. 150 of 431
Better than 65% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 14,657of 69,742
Better than 79%
No. 14,327of 69,964
Better than 80%
Same industry and fewer than 20 employees329 companies in the comparison
No. 53of 323
Better than 84%
No. 96of 329
Better than 71%
Companies that are between 5 and 14 years old33,679 companies in the comparison
No. 9,246of 33,579
Better than 72%
No. 6,157of 33,678
Better than 82%
All companies of type ApS66,508 companies in the comparison
No. 14,925of 66,379
Better than 78%
No. 11,398of 66,505
Better than 83%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. immunAware ApSDKK 4.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. immunAware ApS−DKK 339k
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. immunAware ApSDKK 4.9m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. immunAware ApS8
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Prosal ApS33.33%
  • ASTIM Holding ApS25%
  • T.Ø. Holding ApS25%
immunAware ApS

Management

3 active registrations

Executive management

Executive management at immunAware ApS
NameRoleAppointed
Thomas ØsterbyeDirector19/12/2017
Søren BuusDirector21/06/2018
Anette Stryhn BuusCEO21/06/2018
Founders
Prosal ApS, ASTIM Holding ApS, T.Ø. Holding ApS
Former management (2)
Former management at immunAware ApS
NameRoleAppointedResigned
Søren BuusCEO19/12/201720/06/2018
Anette Stryhn BuusDirector19/12/201720/06/2018

Signing rule: Virksomheden tegnes af hele direktionen i forening, eller af den administrerende direktør alene, eller af to direktører i forening.

Address and production units

2 active production units

Agern Alle 1
2970 Hørsholm

Rudersdal Municipality · Postcode 2970

Other companies at the address (4)

  • Expres2ion Biotechnologies ApSResearch and experimental development on natural sciences and engineering
  • CysBio ApSResearch and experimental development on natural sciences and engineering
  • Tannermedico A/SWholesale of pharmaceutical goods and nursing supplies
  • TOOsonix A/SManufacture of irradiation, electromedical and electrotherapeutic equipment
Production units
Production unitAddressEmployeesP number
immunAware ApSAgern Alle 1, 2970 Hørsholm81023171976
immunAware KUBlegdamsvej 3B, 7, 2200 København N–1024948494

Purpose

Selskabet har til formål at udføre forsknings- og udviklingsaktiviteter med henblik på at tilbyde forskere i hele verden reagenser og service relateret til histocompatibilitets kompleks (MHC) klasse I og II molekyler, og at udføre sådanne aktiviteter, som direktionen skønsmæssigt måtte finde relaterende hertil.

The purpose is quoted from the register in Danish.

Changes year by year

19 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20212 changesaccounts 1 · address 1
  • Annual report for 2020 published
  • Moved to Agern Alle 1, 2970 Hørsholm
20184 changesmanagement 4
  • Søren Buus appointed director
  • Anette Stryhn Buus appointed ceo
  • Søren Buus stepped down as ceo
  • Anette Stryhn Buus stepped down as director
20177 changesfounded 1 · management 3 · ownership 3
  • Registered as immunAware ApS
  • Søren Buus appointed ceo
  • Anette Stryhn Buus appointed director
  • Thomas Østerbye appointed director
  • PROSAL ApS registered as owner (33.33%)
  • ASTIM Holding ApS registered as owner (25%)
  • T.Ø. Holding ApS registered as owner (25%)

Related companies

Same industry in Rudersdal

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction